Schedule 13D ownership disclosure

SERES THERAPEUTICS INC

Security class unavailable · CUSIP: 81750R102

Event date: 2018-04-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.9700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-113170
Form type
SC 13D
Filer
Nestle Health Science US Holdings, Inc.
CIK
CIK 1644164
Filed
Apr 11, 2018
Reporting period
Apr 10, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub